Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Polyplus-transfection
About
Polyplus-transfection develops, markets and sells solutions for the delivery of nucleic acids in research, bioproduction and therapeutics.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €2.50M
- Industries
- Biotechnology,Health Care,Life Science,Therapeutics
- Founded date
- Jan 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 11, 2011 | Series Unknown | €2.50M | 2 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
|
|
— | Series Unknown |
